Standard Biotools annual gross margin
2016
2017
2018
2019
2022
2023
2024
2025
Standard Biotools Gross Margin Growth & History (LAB)
Standard Biotools's gross margin was 49.86% for fiscal 2025.
View full Standard Biotools company overviewStandard Biotools annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 49.86% | +0.54 pp |
| 2024 | 2024-12-31 | 49.32% | +1.88 pp |
| 2023 | 2023-12-31 | 47.44% | +9.61 pp |
| 2022 | 2022-12-31 | 37.83% | −17.00 pp |
| 2019 | 2019-12-31 | 54.83% | +0.25 pp |
| 2018 | 2018-12-31 | 54.57% | +3.58 pp |
| 2017 | 2017-12-31 | 50.99% | −4.96 pp |
| 2016 | 2016-12-31 | 55.95% | — |
Standard Biotools quarterly gross margin
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 52.40% | +3.57 pp |
| Q1 2026 | 2026-03-31 | 53.48% | −1.16 pp |
| Q4 2025 | 2025-12-31 | 47.83% | +250.64 pp |
| Q3 2025 | 2025-09-30 | 48.51% | −6.40 pp |
| Q2 2025 | 2025-06-30 | 48.84% | +2.71 pp |
| Q1 2025 | 2025-03-31 | 54.64% | +1.52 pp |
| Q4 2024 | 2024-12-31 | −202.81% | −250.39 pp |
| Q3 2024 | 2024-09-30 | 54.90% | +10.93 pp |
| Q2 2024 | 2024-06-30 | 46.12% | −3.04 pp |
| Q1 2024 | 2024-03-31 | 53.11% | +4.22 pp |
| Q4 2023 | 2023-12-31 | 47.58% | +11.63 pp |
| Q3 2023 | 2023-09-30 | 43.97% | +20.39 pp |
| Q2 2023 | 2023-06-30 | 49.17% | −5.98 pp |
| Q1 2023 | 2023-03-31 | 48.89% | −4.09 pp |
| Q3 2022 | 2022-09-30 | 35.95% | −18.54 pp |
| Q2 2022 | 2022-06-30 | 23.58% | −32.85 pp |
| Q4 2019 | 2019-12-31 | 55.14% | −3.05 pp |
| Q3 2019 | 2019-09-30 | 52.98% | −1.65 pp |
| Q2 2019 | 2019-06-30 | 54.49% | +3.07 pp |
| Q1 2019 | 2019-03-31 | 56.42% | +3.24 pp |
| Q4 2018 | 2018-12-31 | 58.19% | — |
| Q3 2018 | 2018-09-30 | 54.63% | — |
| Q2 2018 | 2018-06-30 | 51.42% | — |
| Q1 2018 | 2018-03-31 | 53.18% | — |
Standard Biotools gross margin trends
Over the last five reported fiscal years, Standard Biotools's gross margin decreased from 54.57% to 49.86%, a change of −4.72 percentage points. The latest reported quarter, Q2 2026, shows 52.40%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Standard Biotools filings at SEC.gov ↗